Israel HealthCare Ventures Fund I

Israel HealthCare Ventures

Status

ACTIVE

Global HQ

Tel Aviv, Israel

Countries of investment

Israel

Investment stages

Series B
Series C

Industries

About
Israel HealthCare Ventures (IHCV) is a leading Israeli life sciences venture fund established in 2000, dedicated to driving innovation in the healthcare sector. With a diverse portfolio of investments in 27 companies, IHCV specializes in critical areas such as cardiology, oncology, and medical devices. The firm is committed to identifying and nurturing groundbreaking therapeutic solutions that enhance patient care and outcomes. By leveraging its extensive industry expertise and network, IHCV plays a crucial role in advancing the next generation of healthcare technologies.

Min check size: $250K
Max check size: $5M
Fund size: Unlock
NPS: Unlock

Investment Thesis

Investment Thesis: Israel HealthCare Ventures seeks to invest in startups with innovative technologies and solutions in the healthcare sector. The firm targets companies with promising clinical developments, strong management teams, and the potential to transform healthcare delivery. Israel HealthCare Ventures provides capital, mentorship, and strategic support to help its portfolio companies advance their innovations and achieve their growth goals.

Lead investor: Unlock
Co Invest: Unlock
Number of exits: Unlock
Preferred contact method: Unlock

Manager's Experience

With extensive experience in the technology and healthcare sectors, the fund manager has successfully executed over 50 deals across various stages of investment. Active in both North America and Europe, they emphasize a data-driven approach that seeks scalable opportunities. Notable exits include several high-profile companies that have significantly enhanced their portfolio's value. Their strategic style prioritizes operator-first investments, ensuring hands-on involvement in the growth process.